Cyteir Therapeutics
Developing the next generation of synthetic lethal therapies to treat cancer. Learn more
Launch date
Employees
Market cap
$108m
Enterprise valuation
($21m) (Public information from Mar 2024)
Share price
$3.01 CYT
Lexington Kentucky (HQ)
Authorizing premium user...